162 related articles for article (PubMed ID: 15485695)
1. Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin.
Suárez Y; Fernández C; Gómez-Coronado D; Ferruelo AJ; Dávalos A; Martínez-Botas J; Lasunción MA
Cardiovasc Res; 2004 Nov; 64(2):346-55. PubMed ID: 15485695
[TBL] [Abstract][Full Text] [Related]
2. Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Cerrato F; Fernández-Suárez ME; Alonso R; Alonso M; Vázquez C; Pastor O; Mata P; Lasunción MA; Gómez-Coronado D
Br J Pharmacol; 2015 Mar; 172(5):1379-94. PubMed ID: 25395200
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lymphocyte proliferation by cholesterol: the role of endogenous sterol metabolism and low density lipoprotein receptors.
Cuthbert JA; Lipsky PE
Int J Tissue React; 1987; 9(6):447-57. PubMed ID: 3448024
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
5. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes.
Cuthbert JA; Lipsky PE
Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.
Song CY; Kim BC; Lee HS
Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125
[TBL] [Abstract][Full Text] [Related]
7. Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
al Rayyes O; Wallmark A; Florén CH
Hepatology; 1997 Apr; 25(4):991-4. PubMed ID: 9096609
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
9. Effect of reduced levels of the LDL receptor of Ehrlich ascites tumor cells on cholesterol uptake and cell proliferation: a coculture study with baby hamster kidney cells.
Haeffner EW; Wittmann U; Kiesewetter L; Zimmermann HP; Stöhr M; Spiess E
Cell Biol Int; 2007 Aug; 31(8):790-7. PubMed ID: 17349806
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors.
Connelly-Smith L; Pattinson J; Grundy M; Shang S; Seedhouse C; Russell N; Pallis M
Exp Hematol; 2007 Dec; 35(12):1793-800. PubMed ID: 17923246
[TBL] [Abstract][Full Text] [Related]
11. Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells.
Al Rayyes O; Wallmark A; Florén CH
Hepatology; 1997 Oct; 26(4):967-71. PubMed ID: 9328321
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
13. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
14. [HMG-CoA reductase inhibitor for therapy of patients with hyperlipoproteinemia ].
Jingami H
Nihon Rinsho; 1994 Dec; 52(12):3271-8. PubMed ID: 7853722
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.
Messa C; Notarnicola M; Russo F; Cavallini A; Pallottini V; Trentalance A; Bifulco M; Laezza C; Gabriella Caruso M
Scand J Gastroenterol; 2005 Dec; 40(12):1454-61. PubMed ID: 16293557
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin increases surface low density lipoprotein receptor expression by retarding the receptor internalization rate in proliferating lymphocytes.
Chan PC; Lafrenière R; Parsons HG
Biochem Biophys Res Commun; 1997 Jun; 235(1):117-22. PubMed ID: 9196047
[TBL] [Abstract][Full Text] [Related]
17. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.
Massy ZA; Kim Y; Guijarro C; Kasiske BL; Keane WF; O'Donnell MP
Biochem Biophys Res Commun; 2000 Jan; 267(2):536-40. PubMed ID: 10631097
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
20. High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL.
Kascakova S; Nadova Z; Mateasik A; Mikes J; Huntosova V; Refregiers M; Sureau F; Maurizot JC; Miskovsky P; Jancura D
Photochem Photobiol; 2008; 84(1):120-7. PubMed ID: 18173711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
